Scholarlink

Background <p>Perineural invasion (PNI) frequently occurs in oral squamous cell carcinoma (OSCC) and predicts poor prognosis. Although PNI is increasingly recognised as a process driven by tumour-nerve crosstalk, the underlying molecular mechanisms remain unclear. We investigated the role of sympathetic nerve–derived neuropeptide Y (NPY) and its receptor NPY1R in OSCC PNI.</p> Methods <p>NPY/NPY1R expression was assessed in human OSCC tissues by immunostaining, qPCR, and TCGA data analysis. Functional studies using Cal27 and SCC9 cells included migration, invasion, and sphere assays. The causal role of NPY1R was tested by lentiviral knockdown/overexpression, validated in tongue orthotopic xenografts, and further examined by NPY1R pharmacological inhibition in vivo.</p> Results <p>NPY was enriched in the PNI microenvironment, and malignant OSCC expressed high NPY1R, particularly at invasive fronts. Mechanistically, NPY activated ERK and Smad2 via NPY1R, synergising with TGFβ signalling in tumour cells expressing TβRI. This crosstalk enhanced proliferation, invasion, and PNI in vivo. Importantly, NPY1R inhibition markedly reduced tumour growth, metastasis, and PNI.</p> Conclusions <p>We identify NPY-NPY1R-TGFβ crosstalk as a novel mechanism enabling OSCC to exploit neural signals for PNI, highlighting a promising therapeutic target to block neural invasion and improve patient outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Crosstalk of NPY and TGFβ orchestrates the signaling to facilitate perineural invasion of oral squamous cell carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月26日

查看全文
  • Jing Bi,
  • Ketong Liu,
  • Yiru Luo,
  • Yueqi Zhou,
  • Zhengyan Liu,
  • Junting Tao,
  • Jinhui Wei,
  • Marene Landstrom,
  • Yabing Mu,
  • Guangxiang Zang

摘要

Background

Perineural invasion (PNI) frequently occurs in oral squamous cell carcinoma (OSCC) and predicts poor prognosis. Although PNI is increasingly recognised as a process driven by tumour-nerve crosstalk, the underlying molecular mechanisms remain unclear. We investigated the role of sympathetic nerve–derived neuropeptide Y (NPY) and its receptor NPY1R in OSCC PNI.

Methods

NPY/NPY1R expression was assessed in human OSCC tissues by immunostaining, qPCR, and TCGA data analysis. Functional studies using Cal27 and SCC9 cells included migration, invasion, and sphere assays. The causal role of NPY1R was tested by lentiviral knockdown/overexpression, validated in tongue orthotopic xenografts, and further examined by NPY1R pharmacological inhibition in vivo.

Results

NPY was enriched in the PNI microenvironment, and malignant OSCC expressed high NPY1R, particularly at invasive fronts. Mechanistically, NPY activated ERK and Smad2 via NPY1R, synergising with TGFβ signalling in tumour cells expressing TβRI. This crosstalk enhanced proliferation, invasion, and PNI in vivo. Importantly, NPY1R inhibition markedly reduced tumour growth, metastasis, and PNI.

Conclusions

We identify NPY-NPY1R-TGFβ crosstalk as a novel mechanism enabling OSCC to exploit neural signals for PNI, highlighting a promising therapeutic target to block neural invasion and improve patient outcomes.